Trademark: 79318935
Status Date
Thursday, November 3, 2022
Filing Date
Thursday, July 15, 2021
Abandoned Date
Monday, October 24, 2022
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, all of the foregoing goods excluding botulinim toxin
Nov 27, 2023
Final Decision Transaction Processed By Ib
Nov 3, 2023
Final Disposition Notice Sent To Ib
Nov 3, 2023
Final Disposition Notice Created, To Be Sent To Ib
Mar 20, 2023
Notification Of Possible Opposition - Processed By Ib
Feb 22, 2023
Notification Of Possible Opposition Sent To Ib
Feb 22, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 3, 2022
Abandonment Notice E-Mailed - Failure To Respond
Nov 3, 2022
Abandonment Notice Mailed - Failure To Respond
Nov 3, 2022
Abandonment - Failure To Respond Or Late Response
Apr 22, 2022
Notification Of Final Refusal Emailed
Apr 22, 2022
Final Refusal E-Mailed
Apr 22, 2022
Final Refusal Written
Mar 23, 2022
Teas/Email Correspondence Entered
Mar 23, 2022
Correspondence Received In Law Office
Mar 23, 2022
Teas Response To Office Action Received
Dec 12, 2021
Refusal Processed By Ib
Nov 18, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Nov 18, 2021
Refusal Processed By Mpu
Oct 22, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Oct 21, 2021
Non-Final Action Written
Oct 18, 2021
Preliminary/Voluntary Amendment - Entered
Oct 18, 2021
Teas Voluntary Amendment Received
Oct 16, 2021
Assigned To Examiner
Oct 5, 2021
Correction From Ib Entered - No Review Required
Sep 19, 2021
Correction Transaction Received From Ib
Sep 15, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 15, 2021
Teas Change Of Owner Address Received
Sep 7, 2021
Application Filing Receipt Mailed
Sep 3, 2021
New Application Office Supplied Data Entered
Sep 2, 2021
Limitation From Original Application Entered
Aug 26, 2021
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
